Megalin As a Metabolic Modulator in the Kidney and Beyond

Overview

Journal Function (Oxf)

Publisher Oxford University Press

Date 2024 Jul 10

PMID 38984972

Authors

Rebekah J Nicholson

Nirupama Ramkumar

Aylin R Rodan

Affiliations

Soon will be listed here.

References

OHara D, Lam C, McMurray J, Yi T, Hocking S, Dawson J . Applications of SGLT2 inhibitors beyond glycaemic control. Nat Rev Nephrol. 2024; 20(8):513-529. DOI: 10.1038/s41581-024-00836-y. View

Kuwahara S, Hosojima M, Kaneko R, Aoki H, Nakano D, Sasagawa T . Megalin-Mediated Tubuloglomerular Alterations in High-Fat Diet-Induced Kidney Disease. J Am Soc Nephrol. 2015; 27(7):1996-2008. PMC: 4926965. DOI: 10.1681/ASN.2015020190. View

Osataphan S, Macchi C, Singhal G, Chimene-Weiss J, Sales V, Kozuka C . SGLT2 inhibition reprograms systemic metabolism via FGF21-dependent and -independent mechanisms. JCI Insight. 2019; 4(5). PMC: 6483601. DOI: 10.1172/jci.insight.123130. View

Nielsen R, Ilso Christensen E, Birn H . Megalin and cubilin in proximal tubule protein reabsorption: from experimental models to human disease. Kidney Int. 2016; 89(1):58-67. DOI: 10.1016/j.kint.2015.11.007. View

Long K, Rbaibi Y, Bondi C, Ford B, Poholek A, Boyd-Shiwarski C . Cubilin-, megalin-, and Dab2-dependent transcription revealed by CRISPR/Cas9 knockout in kidney proximal tubule cells. Am J Physiol Renal Physiol. 2021; 322(1):F14-F26. PMC: 8698540. DOI: 10.1152/ajprenal.00259.2021. View

Pyrzynska B, Pilecka I, Miaczynska M . Endocytic proteins in the regulation of nuclear signaling, transcription and tumorigenesis. Mol Oncol. 2009; 3(4):321-38. PMC: 5527948. DOI: 10.1016/j.molonc.2009.06.001. View

Youm E, Shipman K, Albalawy W, Vandevender A, Sipula I, Rbaibi Y . Megalin Knockout Reduces SGLT2 Expression and Sensitizes to Western Diet-induced Kidney Injury. Function (Oxf). 2024; 5(4). PMC: 11237895. DOI: 10.1093/function/zqae026. View

Rbaibi Y, Long K, Shipman K, Ren Q, Baty C, Kashlan O . Megalin, cubilin, and Dab2 drive endocytic flux in kidney proximal tubule cells. Mol Biol Cell. 2023; 34(7):ar74. PMC: 10295476. DOI: 10.1091/mbc.E22-11-0510. View

Gyimesi G, Pujol-Gimenez J, Kanai Y, Hediger M . Sodium-coupled glucose transport, the SLC5 family, and therapeutically relevant inhibitors: from molecular discovery to clinical application. Pflugers Arch. 2020; 472(9):1177-1206. PMC: 7462921. DOI: 10.1007/s00424-020-02433-x. View

10.

Jurczak M, Saini S, Ioja S, Costa D, Udeh N, Zhao X . SGLT2 knockout prevents hyperglycemia and is associated with reduced pancreatic β-cell death in genetically obese mice. Islets. 2018; 10(5):181-189. PMC: 6284495. DOI: 10.1080/19382014.2018.1503027. View